Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

Item
http://www.wikidata.org/entity/Q24538962
Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideMonoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.Behavioural toxicity of antidepressants with particular reference to moclobemideInitial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depressionReversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.Brain monoamine oxidase A inhibition in cigarette smokers.5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjects.Biological and histopathological investigations of moclobemide on injured ovarian tissue following induction of ischemia-reperfusion in rats.Investigation of antiulcer and antioxidant activity of moclobemide in rats.In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence.Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects.Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.
P2860

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

Item
http://www.wikidata.org/entity/Q24538962
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Comparison of the monoamine ox ...... erformance in healthy subjects
@ast
Comparison of the monoamine ox ...... erformance in healthy subjects
@en
Comparison of the monoamine ox ...... erformance in healthy subjects
@nl
type
label
Comparison of the monoamine ox ...... erformance in healthy subjects
@ast
Comparison of the monoamine ox ...... erformance in healthy subjects
@en
Comparison of the monoamine ox ...... erformance in healthy subjects
@nl
prefLabel
Comparison of the monoamine ox ...... erformance in healthy subjects
@ast
Comparison of the monoamine ox ...... erformance in healthy subjects
@en
Comparison of the monoamine ox ...... erformance in healthy subjects
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Comparison of the monoamine ox ...... erformance in healthy subjects
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.1990.TB05445.X
P407
P433
P478
P577
P5875
P698
P932